Literature DB >> 6386769

Thromboxane and prostacyclin synthesis following whole body irradiation in rats.

M J Schneidkraut, P A Kot, P W Ramwell, J C Rose.   

Abstract

The effect of radiation on the mechanism and source of in vivo thromboxane B2 (TxB2) and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) synthesis was evaluated. Rats were irradiated with 2, 10, or 20 gray (Gy) whole-body gamma irradiation and showed an increase in urine TxB2 after either 10 or 20 Gy. Urine 6-keto-PGF1 alpha was elevated only after exposure to 20 Gy. Irradiation did not alter urine volume or osmolarity, nor was there a correlation between urine osmolarity and the urinary concentration of TxB2 r 6-keto-PGF1 alpha. Rats were pretreated with indomethacin to determine if radiation-induced alterations in urine TxB2 and 6-keto-PGF1 alpha could be suppressed. Pretreatment with indomethacin significantly decreased urine TxB2 and 6-keto-PGF1 alpha in both irradiated and nonirradiated animals. Finally, the sources of urinary cyclooxygenase products were investigated using an isogravitometric cross-perfusion system. These experiments demonstrated that urine TxB2 is derived from extrarenal sources, whereas 6-keto-PGF1 alpha is synthesized primarily by the kidney. It may be concluded that radiation exposure increases in vivo cyclooxygenase pathway activity by both renal and extrarenal tissues.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386769     DOI: 10.1152/jappl.1984.57.3.833

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  2 in total

Review 1.  Radiation metabolomics and its potential in biodosimetry.

Authors:  Stephen L Coy; Amrita K Cheema; John B Tyburski; Evagelia C Laiakis; Sean P Collins; Albert Fornace
Journal:  Int J Radiat Biol       Date:  2011-06-22       Impact factor: 2.694

2.  The modulation of radiation-induced damage to pig skin by essential fatty acids.

Authors:  J W Hopewell; M E Robbins; G J van den Aardweg; G M Morris; G A Ross; E Whitehouse; D F Horrobin; C A Scott
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.